23-Sep-2009 - Labcyte Inc.

Labcyte Signs Bioscreen Instruments as Exclusive Distributor in India

Labcyte announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India. “Bioscreen is a leading distributor in India. They will be a great partner for us,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we continue to expand throughout Asia, Bioscreen will help us further broaden our existing user base in the pharmaceutical industry and the contract research organizations (CROs) that service them, Bioscreen will provide them with industry-leading Labcyte acoustic technology for compound management, high-throughput and secondary screening. Bioscreen will give our new customers in India immediate support and interaction. “We are extremely pleased to be the Labcyte partner in India. It is a great recognition of our distributor capabilities across the entire country of India. Labcyte products will allow us to provide our customers with state-of-the-art platform technology so that they can excel in their efforts,” said Mr. S. Radha Krishnan, Managing Director of Bioscreen Instruments. “We see a great potential market for low-volume liquid handlers in India. We believe that the miniaturization capabilities provided by Labcyte technology will be especially useful for the growing genomics markets, especially for gene expression, SNP analysis and RNAi.”

Facts, background information, dossiers
  • Labcyte
  • Bioscreen Instruments
  • genomics
  • gene expression
  • contract research
  • bases
More about Labcyte
  • News

    Beckman Coulter strenghtens laboratory automation business

    Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with une ... more

    Labcyte Awarded 1st Patent in China

    Labcyte announced the grant of its first patent in China. Patent CN 101035681B describes how acoustic energy is used to assess the characteristics of any fluid in real time to optimize its transfer. The Labcyte acoustic droplet ejection technology offers touchless transfer of a wide variety ... more

    Labcyte Awarded US Patent for Real-Time Power Optimization

    Labcyte announced the grant of its 40th US patent. Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid, even those that are unknown. Labcyte’s acoustic droplet ejection technology offers touchless transfer of a wide variety of f ... more